Demyelinating Risk with TNF Inhibitors versus Other Targeted DMARDs in Rheumatoid Arthritis: A French Nationwide Claims Study (DEMY-TNF) First published 05/06/2026 Last updated 05/06/2026 EU PAS number:EUPAS1000001021 Study Ongoing